V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212334 | 20078984 | 1.8 | 75.4 | Curative (C) | 2017-05-13 | 2017-05-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101484850 |
| 20212335 | 20078985 | 1.66 | 57.9 | Curative (C) | 2017-04-09 | 2017-04-23 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100702631 |
| 20212336 | 20078986 | 1.74 | 76 | Palliative (P) | 2017-08-27 | 2017-09-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100808524 |
| 20212337 | 20078987 | 1.78 | 67.6 | Curative (C) | 2018-09-11 | 2018-09-14 | CAPECITABINE + CARBOPLATIN | 02 | Y | TRIAL UNSPECIFIED | 101321361 |
| 20212340 | 20078988 | 1.66 | 75.4 | Curative (C) | null | 2017-12-29 | CAPECITABINE + CARBOPLATIN | N | N | CISPLATIN + FLUOROURACIL | 100176778 |
| 20212341 | 20078989 | 1.64 | 90.5 | Curative (C) | 2017-06-04 | 2017-06-18 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101051931 |
| 20212342 | 20078990 | 1.43 | 54 | Neo-adjuvant (N) | 2018-03-01 | 2018-03-03 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101204975 |
| 20212343 | 20078991 | 1.63 | 64.75 | Neo-adjuvant (N) | null | 2018-04-09 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 100625968 |
| 20212344 | 20078992 | 0 | 0 | null | 2019-10-16 | 2019-11-04 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101598091 |
| 20212345 | 20078993 | 1.65 | 72.3 | null | 2019-07-17 | 2019-07-25 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101743027 |
| 20212346 | 20078994 | 1.75 | 69.1 | Palliative (P) | 2018-06-30 | 2018-07-13 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100596623 |
| 20212347 | 20078995 | 1.6 | 65.2 | Curative (C) | 2016-03-14 | 2016-03-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100714254 |
| 20212349 | 20078996 | 0 | 57 | 03 | 2019-06-09 | 2019-07-10 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100759615 |
| 20212351 | 20078997 | 1.5 | 67.2 | Neo-adjuvant (N) | 2017-03-08 | 2017-03-24 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101288708 |
| 20212353 | 20078998 | 1.73 | 56.6 | Neo-adjuvant (N) | 2018-11-03 | 2018-11-03 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101005403 |
| 20212355 | 20078999 | 0 | 0 | Neo-adjuvant (N) | 2018-02-04 | 2018-04-09 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101498137 |
| 20212357 | 20079000 | 1.86 | 96.1 | Neo-adjuvant (N) | 2019-07-27 | 2019-08-04 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101148526 |
| 20212358 | 20079001 | 1.75 | 75.5 | Palliative (P) | 2016-07-06 | 2016-07-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101474111 |
| 20212360 | 20079002 | 1.78 | 68 | Palliative (P) | 2019-12-19 | 2019-12-19 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101344743 |
| 20212361 | 20079003 | 1.79 | 61.8 | Palliative (P) | 2019-05-07 | 2019-05-18 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100049025 |
| 20212362 | 20079004 | 1.5 | 64 | Curative (C) | 2018-04-09 | 2018-04-21 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101030401 |
| 20212363 | 20079005 | 1.74 | 64 | Neo-adjuvant (N) | 2019-05-10 | 2019-05-10 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101059674 |
| 20212366 | 20079006 | 1.63 | 132.9 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-27 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101472047 |
| 20212369 | 20079007 | 0 | 0 | Palliative (P) | null | 2018-12-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100787232 |
| 20212370 | 20079008 | 1.79 | 104.4 | null | null | 2016-10-28 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100124290 |
| 20212371 | 20079009 | 0 | 0 | Curative (C) | 2017-06-10 | 2017-07-01 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100310925 |
| 20212372 | 20079010 | 1.65 | 64.7 | Neo-adjuvant (N) | 2017-05-23 | 2017-05-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101265509 |
| 20212373 | 20079011 | 1.78 | 69.5 | Curative (C) | 2017-10-02 | 2017-10-02 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101033804 |
| 20212374 | 20079012 | 1.62 | 89.6 | Palliative (P) | null | 2016-11-21 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100733027 |
| 20212375 | 20079013 | 1.6 | 59 | null | 2017-07-06 | 2017-07-11 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101594519 |
| 20212376 | 20079014 | 1.64 | 51.4 | Palliative (P) | 2020-03-11 | 2020-03-11 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100930999 |
| 20212378 | 20079015 | 1.43 | 80 | Curative (C) | 2018-10-12 | 2018-10-12 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101509901 |
| 20212379 | 20079016 | 1.69 | 113 | Palliative (P) | 2019-04-15 | 2019-08-12 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100270664 |
| 20212380 | 20079017 | 1.71 | 68.4 | null | 2018-01-01 | 2018-01-09 | Capecitabine (21days) + Carboplatin | 02 | null | TRIAL UNSPECIFIED | 101689472 |
| 20212381 | 20079018 | 0 | 0 | null | 2018-01-16 | 2018-01-27 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101719806 |
| 20212382 | 20079019 | 1.8 | 87.1 | Neo-adjuvant (N) | 2019-10-04 | 2019-10-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101340261 |
| 20212383 | 20079020 | null | null | Curative (C) | null | 2019-04-04 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101689123 |
| 20212384 | 20079021 | 0 | 0 | Curative (C) | 2018-07-16 | 2018-08-14 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100260036 |
| 20212385 | 20079022 | 1.71 | 82.7 | Neo-adjuvant (N) | 2016-10-30 | 2016-11-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100623997 |
| 20212386 | 20079023 | 0 | 0 | Neo-adjuvant (N) | 2018-02-15 | 2018-03-08 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101207401 |
| 20212387 | 20079024 | 1.54 | 59.4 | Palliative (P) | 2019-02-27 | 2019-03-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101193011 |
| 20212389 | 20079025 | 1.7 | 55.1 | Palliative (P) | 2018-10-30 | 2018-11-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101864106 |
| 20212390 | 20079026 | 1.85 | 76.1 | Neo-adjuvant (N) | 2017-12-14 | 2018-01-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100249390 |
| 20212391 | 20079027 | 1.7 | 53 | Curative (C) | 2018-05-11 | 2018-05-23 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100476142 |
| 20212392 | 20079028 | 0 | 0 | Curative (C) | null | 2018-03-04 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 101465923 |
| 20212393 | 20079029 | 1.73 | 69 | Palliative (P) | null | 2018-07-16 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100060888 |
| 20212394 | 20079030 | null | null | Neo-adjuvant (N) | null | 2017-04-15 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101367110 |
| 20212395 | 20079031 | 1.78 | null | Palliative (P) | 2018-03-01 | 2018-03-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100357021 |
| 20212398 | 20079032 | 1.65 | 51.6 | Palliative (P) | 2017-07-22 | 2017-07-22 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101482106 |
| 20212399 | 20079033 | null | 83.2 | null | 2018-12-12 | 2018-12-20 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100303831 |